Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Lupin Launches Generic Safyral Tablets In The Us

Lupin Launches Generic Safyral Tablets In The Us

Chemical Weekly 2018-03-29

Pharma major Lupin has announced the launch of its Tydemy Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3 mg/0.03 mg/0.451 mg and Levomefolate Calcium, 0.451 mg) having received an approval from the USFDA earlier. The drug is the generic equivalent of Bayer HealthCare Pharmaceuticals Inc.’s Safyral tablets, which are indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception. It had annual sales of approximately $22-mn in the US.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.